RTW Biotech Opportunities (LON:RTW – Get Free Report) shares dropped 0.5% during trading on Tuesday . The stock traded as low as GBX 2.51 and last traded at GBX 2.53. 696,913 shares changed hands during mid-day trading, a decline of 2% from the average daily volume of 713,898 shares. The stock had previously closed at GBX 2.54.
RTW Biotech Opportunities Stock Down 0.5%
The company has a quick ratio of 0.81, a current ratio of 0.15 and a debt-to-equity ratio of 20.05. The company has a 50 day simple moving average of GBX 2.44 and a two-hundred day simple moving average of GBX 2.22. The company has a market capitalization of £8.16 million, a P/E ratio of 0.04 and a beta of 0.77.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
